P&G Health Q1 Results: One-Off Asset Sale Lifts Profit 45%; Stock Declines 5%
Key Takeaways
- •Net profit rose 45% year on year in the quarter ended June 2026.
- •The profit increase was supported by steady sales growth, improved execution, and a one-off asset-sale gain.
- •The company said consumer demand remained healthy during the quarter.
- •P&G Health shares fell about 5% after the results were announced.
P&G Health Q1 Results: One-Off Asset Sale Lifts Profit 45%; Stock Declines 5%
Procter & Gamble Health Ltd reported its financial results for the quarter ended June 2026, posting a 45% year-on-year increase in net profit. The earnings growth was supported by steady sales growth, improved execution, and a one-off gain from an asset sale.
The company stated that consumer demand remained healthy during the quarter, underscoring that the quarter’s profit increase was not driven by demand weakness or a single operating lever alone. At the same time, the asset-sale gain makes the headline profit figure less directly comparable with future quarters, so investors will typically look more closely at underlying sales trends and operating performance in subsequent updates.
Despite the strong profit performance, shares of P&G Health fell approximately 5% following the results announcement.
Procter & Gamble Health Ltd, formerly known as Merck Ltd (India), is a publicly listed company on Indian stock exchanges. The company is part of the broader Procter & Gamble group and is primarily engaged in the marketing and distribution of health and personal care products.
Source: CNBC-TV18 Markets
